Estrella Immunopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,084 | -2,292 | -613 | -4,801 |
EBIT | -2,084 | -2,292 | -613 | -4,801 |
Net Income | -2,306 | -2,292 | -613 | -4,801 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,780 | -6,698 | -177 | -727 |
Cash | 146 | 1,927 | 1,384 | 1,626 |
Basic Shares | 42,997 | 42,121 | 37,970 | 37,096 |
Annual Financials
| Values in thousands | 2025-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -13,062 | -7,310 | -11,114 |
EBIT | -13,062 | -7,310 | -915 |
Net Income | -13,063 | -7,311 | -11,114 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,785 | -16,068 | -1,043 |
Cash | 1,384 | 4,165 | 40 |
Basic Shares | 36,820 | 36,289 | 35,201 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.05 |
2026-03-31 | -$0.05 |
2025-12-31 | -$0.01 |
2025-09-30 | -$0.13 |